Stockscreener 앱 받기
27.02
2.92%
0.805
전일 마감가:
$26.21
열려 있는:
$26.42
하루 거래량:
173.53K
Relative Volume:
0.31
시가총액:
$793.71M
수익:
$17.16M
순이익/손실:
$-163.62M
주가수익비율:
-4.4433
EPS:
-6.08
순현금흐름:
$-121.61M
1주 성능:
+0.43%
1개월 성능:
+18.21%
6개월 성능:
+62.21%
1년 성능:
-27.02%
1일 변동 폭
$26.16
$27.38
1주일 범위
$25.48
$27.46
52주 변동 폭
$12.21
$41.31
Anaptysbio Inc Stock (ANAB) Company Profile
명칭
Anaptysbio Inc
전화
858-362-6295
주소
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
ANAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANAB
Anaptysbio Inc
|
27.02 | 782.40M | 17.16M | -163.62M | -121.61M | -6.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.10 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.88 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.27 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
574.20 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.30 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-12-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-07-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-04-16 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Wells Fargo | Overweight |
| 2024-03-12 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2024-02-26 | 개시 | BTIG Research | Buy |
| 2024-02-21 | 개시 | Stifel | Buy |
| 2024-02-16 | 개시 | Piper Sandler | Overweight |
| 2023-05-22 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-05-18 | 개시 | TD Cowen | Outperform |
| 2023-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-09-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-09-01 | 개시 | Raymond James | Outperform |
| 2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-06-22 | 개시 | H.C. Wainwright | Buy |
| 2021-05-21 | 개시 | UBS | Neutral |
| 2021-03-16 | 업그레이드 | Truist | Hold → Buy |
| 2021-03-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-08 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2021-02-11 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2020-10-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-10-14 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-11-08 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2019-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-11-08 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-11-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-06-21 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-12-20 | 개시 | H.C. Wainwright | Buy |
| 2018-11-21 | 개시 | JP Morgan | Overweight |
| 2018-07-19 | 개시 | Credit Suisse | Outperform |
| 2018-04-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | 재확인 | Stifel | Buy |
| 2018-03-06 | 재확인 | Stifel | Buy |
| 2018-02-15 | 재확인 | SunTrust | Buy |
| 2018-01-23 | 재확인 | Credit Suisse | Outperform |
| 2017-11-15 | 개시 | SunTrust | Buy |
| 2017-11-09 | 개시 | Jefferies | Buy |
| 2017-10-11 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
AnaptysBio Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockHigh-yield portfolio picks - jammulinksnews.com
How AnaptysBio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
Is AnaptysBio Inc. a good long term investmentConsistent high-yield stocks - jammulinksnews.com
What drives AnaptysBio Inc. stock priceFree Stock Market Knowledge Sharing - jammulinksnews.com
AnaptysBio, Inc.'s (NASDAQ:ANAB) Share Price Not Quite Adding Up - simplywall.st
What makes AnaptysBio Inc. stock price move sharplyShort Squeeze Radar - Newser
Why AnaptysBio Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
AnaptysBio (ANAB) Soars 2.86% on Two Sigma Stake Increase - AInvest
AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB) - Seeking Alpha
(ANAB) Trading Report - news.stocktradersdaily.com
AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.6%What's Next? - MarketBeat
Moody Aldrich Partners LLC Acquires New Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Director Sells $493,202.25 in Stock - MarketBeat
AnaptysBio, Inc. (ANAB) Stock Analysis: A High-Risk, High-Reward Bet with a 79% Potential Upside - DirectorsTalk Interviews
(ANAB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Farther Finance Advisors LLC Increases Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
GAMMA Investing LLC Acquires New Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
When the Price of (ANAB) Talks, People Listen - news.stocktradersdaily.com
Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Assenagon Asset Management S.A. Has $4.51 Million Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Holdings Trimmed by Bank of America Corp DE - MarketBeat
AnaptysBio Holds 2025 Annual Stockholders Meeting - TipRanks
Bank of America Corp DE Lowers Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by California State Teachers Retirement System - Defense World
FMR LLC Significantly Reduces Stake in AnaptysBio Inc - GuruFocus
Stocks With Rising Relative Price Strength: AnaptysBio - Investor's Business Daily
JPMorgan Sees AnaptysBio (ANAB) as Undervalued Due to Rosnilimab - GuruFocus
Shareholders May Be More Conservative With AnaptysBio, Inc.'s (NASDAQ:ANAB) CEO Compensation For Now - simplywall.st
New RA Drug Shown to Work, Be Safe - streetwisereports.com
AnaptysBio: Rosnilimab's RA Data Sets The Stage For Blockbuster Potential (NASDAQ:ANAB) - Seeking Alpha
ANAB Schedules June 9 Conference Call with JPMorgan | ANAB Stock News - GuruFocus
Brokerages Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $42.38 - MarketBeat
AnaptysBio (NASDAQ:ANAB) Trading Down 4.5%Time to Sell? - MarketBeat
AnaptysBio (NASDAQ:ANAB) Upgraded by HC Wainwright to "Buy" Rating - MarketBeat
AnaptysBio (NASDAQ:ANAB) Shares Gap UpHere's What Happened - MarketBeat
Anaptysbio Inc (ANAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anaptysbio Inc 주식 (ANAB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RENTON HOLLINGS | Director |
Jul 02 '25 |
Sale |
23.57 |
20,925 |
493,191 |
4,965 |
4.50%
0.24%
자본화:
|
볼륨(24시간):